The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview

Aggressive histological subtypes of thyroid cancer are rare and have a poor prognosis. The most important aggressive subtypes of thyroid cancer are Hürthle cell carcinoma (HCTC) and anaplastic and poorly differentiated carcinoma (ATC and PDTC). The American Thyroid Association recently published gui...

Full description

Saved in:
Bibliographic Details
Main Authors: Giorgio Treglia, Salvatore Annunziata, Barbara Muoio, Massimo Salvatori, Luca Ceriani, Luca Giovanella
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/856189
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849398886848790528
author Giorgio Treglia
Salvatore Annunziata
Barbara Muoio
Massimo Salvatori
Luca Ceriani
Luca Giovanella
author_facet Giorgio Treglia
Salvatore Annunziata
Barbara Muoio
Massimo Salvatori
Luca Ceriani
Luca Giovanella
author_sort Giorgio Treglia
collection DOAJ
description Aggressive histological subtypes of thyroid cancer are rare and have a poor prognosis. The most important aggressive subtypes of thyroid cancer are Hürthle cell carcinoma (HCTC) and anaplastic and poorly differentiated carcinoma (ATC and PDTC). The American Thyroid Association recently published guidelines for the management of patients with ATC, but no specific guidelines have been done about HCTC. We performed an overview of the literature about the role of Fluorine-18-Fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography (FDG-PET or PET/CT) in aggressive histological subtypes of thyroid cancer. Only few original studies about the role of FDG-PET or PET/CT in HCTC, PDTC, and ATC have been published in the literature. FDG-PET or PET/CT seems to be useful in staging or followup of invasive and metastatic HCTC. FDG-PET or PET/CT should be used in patients with ATC in initial staging and in the followup after surgery to evaluate metastatic disease. Some authors suggest the use of FDG-PET/CT in staging of PDTC, but more studies are needed to define the diagnostic use of FDG-PET/CT in this setting. Limited experience suggests the usefulness of FDG-PET or PET/CT in patients with more aggressive histological subtypes of DTC. However, DTC presenting as radioiodine refractory and FDG-PET positive should be considered aggressive tumours with poor prognosis.
format Article
id doaj-art-9ef1aae8f18f421d8a2fdde70893edcf
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-9ef1aae8f18f421d8a2fdde70893edcf2025-08-20T03:38:30ZengWileyInternational Journal of Endocrinology1687-83371687-83452013-01-01201310.1155/2013/856189856189The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An OverviewGiorgio Treglia0Salvatore Annunziata1Barbara Muoio2Massimo Salvatori3Luca Ceriani4Luca Giovanella5Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, SwitzerlandInstitute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli 8, 00168 Rome, ItalySchool of Medicine, Catholic University of the Sacred Heart, Largo Vito 1, 00168 Rome, ItalyInstitute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli 8, 00168 Rome, ItalyDepartment of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, SwitzerlandDepartment of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, SwitzerlandAggressive histological subtypes of thyroid cancer are rare and have a poor prognosis. The most important aggressive subtypes of thyroid cancer are Hürthle cell carcinoma (HCTC) and anaplastic and poorly differentiated carcinoma (ATC and PDTC). The American Thyroid Association recently published guidelines for the management of patients with ATC, but no specific guidelines have been done about HCTC. We performed an overview of the literature about the role of Fluorine-18-Fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography (FDG-PET or PET/CT) in aggressive histological subtypes of thyroid cancer. Only few original studies about the role of FDG-PET or PET/CT in HCTC, PDTC, and ATC have been published in the literature. FDG-PET or PET/CT seems to be useful in staging or followup of invasive and metastatic HCTC. FDG-PET or PET/CT should be used in patients with ATC in initial staging and in the followup after surgery to evaluate metastatic disease. Some authors suggest the use of FDG-PET/CT in staging of PDTC, but more studies are needed to define the diagnostic use of FDG-PET/CT in this setting. Limited experience suggests the usefulness of FDG-PET or PET/CT in patients with more aggressive histological subtypes of DTC. However, DTC presenting as radioiodine refractory and FDG-PET positive should be considered aggressive tumours with poor prognosis.http://dx.doi.org/10.1155/2013/856189
spellingShingle Giorgio Treglia
Salvatore Annunziata
Barbara Muoio
Massimo Salvatori
Luca Ceriani
Luca Giovanella
The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
International Journal of Endocrinology
title The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
title_full The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
title_fullStr The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
title_full_unstemmed The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
title_short The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
title_sort role of fluorine 18 fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer an overview
url http://dx.doi.org/10.1155/2013/856189
work_keys_str_mv AT giorgiotreglia theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT salvatoreannunziata theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT barbaramuoio theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT massimosalvatori theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT lucaceriani theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT lucagiovanella theroleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT giorgiotreglia roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT salvatoreannunziata roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT barbaramuoio roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT massimosalvatori roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT lucaceriani roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview
AT lucagiovanella roleoffluorine18fluorodeoxyglucosepositronemissiontomographyinaggressivehistologicalsubtypesofthyroidcanceranoverview